JP2016513523A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513523A5
JP2016513523A5 JP2015562517A JP2015562517A JP2016513523A5 JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5 JP 2015562517 A JP2015562517 A JP 2015562517A JP 2015562517 A JP2015562517 A JP 2015562517A JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5
Authority
JP
Japan
Prior art keywords
solution
item
bile
seq
target area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015562517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/059765 external-priority patent/WO2014141160A1/en
Publication of JP2016513523A publication Critical patent/JP2016513523A/ja
Publication of JP2016513523A5 publication Critical patent/JP2016513523A5/ja
Pending legal-status Critical Current

Links

JP2015562517A 2013-03-14 2014-03-13 胆汁漏の処置 Pending JP2016513523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784496P 2013-03-14 2013-03-14
US61/784,496 2013-03-14
PCT/IB2014/059765 WO2014141160A1 (en) 2013-03-14 2014-03-13 Treatment for bile leakage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018079164A Division JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Publications (2)

Publication Number Publication Date
JP2016513523A JP2016513523A (ja) 2016-05-16
JP2016513523A5 true JP2016513523A5 (enExample) 2017-04-13

Family

ID=50397217

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562517A Pending JP2016513523A (ja) 2013-03-14 2014-03-13 胆汁漏の処置
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Country Status (5)

Country Link
US (1) US20160030628A1 (enExample)
EP (1) EP2968654A1 (enExample)
JP (2) JP2016513523A (enExample)
HK (1) HK1220145A1 (enExample)
WO (1) WO2014141160A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2694000T3 (es) 2008-10-06 2018-12-17 3-D Matrix Ltd. Tapón de tejido
ES2706065T3 (es) 2012-07-06 2019-03-27 3 D Matrix Ltd Proceso de llenado-acabado para soluciones de péptidos
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
BR112016020584A2 (pt) 2014-03-10 2017-10-03 3 D Matrix Ltd Composições de peptídeo auto-organizável
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
KR20190022455A (ko) * 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법
WO2017158435A1 (en) * 2016-03-18 2017-09-21 3-D Matrix, Ltd. Cerebrospinal fluid leakage occlusion
BR112018068838A2 (pt) * 2016-03-18 2019-01-22 3 D Matrix Ltd oclusão de fístula pancreática
US11534528B2 (en) 2020-03-31 2022-12-27 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1843776A4 (en) * 2004-07-06 2011-05-11 3D Matrix Inc PURIFIED AMPHILIC PEPTIDE COMPOSITIONS AND ITS USE
KR20080007380A (ko) * 2005-04-25 2008-01-18 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및방법
ES2694000T3 (es) * 2008-10-06 2018-12-17 3-D Matrix Ltd. Tapón de tejido
US8962784B2 (en) * 2008-12-19 2015-02-24 Ethicon, Inc. Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant

Similar Documents

Publication Publication Date Title
JP2016513523A5 (enExample)
JP2016515113A5 (enExample)
Tyler et al. Nanomedicine for treating spinal cord injury
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
JP2017513927A5 (enExample)
JP2017519568A5 (enExample)
JP2017513928A5 (enExample)
JP2018130552A (ja) 胆汁漏の処置
JP2016501066A5 (enExample)
WO2018033744A1 (en) Carrier
JP2016515113A (ja) 消化管閉塞の予防のための材料
JP2017513927A (ja) 肺の漏出を治療するための自発組織化ペプチド
EP4309722A3 (en) Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
RU2016127558A (ru) Стероидное соединение для применения в лечении печеночной энцефалопатии
KR102200656B1 (ko) 마이크로스피어를 포함하는 개선된 창상 치료 조성물
JP2019508175A (ja) 膵液瘻の閉鎖
JP2016535044A (ja) 次亜塩素酸ナトリウムを含む抗炎症溶液
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
JP5822724B2 (ja) 疼痛、炎症、ニューロンもしくは血管損傷に対する生物学的マーカーおよび治療への応答、ならびにその使用方法
RU2018100879A (ru) Быстродействующая распадающаяся в ротовой полости пленка для проведения местного обезболивания
JP2019518569A5 (enExample)
JP2019518569A (ja) 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola
Sale et al. Cannula-based drug delivery to the guinea pig round window causes a lasting hearing loss that may be temporarily mitigated by BDNF
AU2021325682A1 (en) Antimicrobial matrix formed from peptide hydrogels